Issues lobbied + lobbyists (13)
MMM — Medicare/Medicaid
Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to DME competitive bidding Issues related to non-opioid pain therapies Issues related to transcatheter heart valves
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TAX — Taxation/Internal Revenue Code
Issues related to the taxation of multinational corporations corporations
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TRD — Trade (domestic/foreign)
Issues related to global supply chains including rare earth and critical minerals including S.3658 the Securing Essential and Critical U.S. Resources and Elements Minerals Act of 2026 Issues related to tariffs
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
HCR — Health Issues
Issues related to medical device electronic labeling, including H.R. 1539 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to diabetes Issues related to epilepsy Issues related to overactive bladder and urinary incontinence
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TEC — Telecommunications
Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
LBR — Labor Issues/Antitrust/Workplace
Issues related to anti-trust and competition
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
CPT — Copyright/Patent/Trademark
Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
ENV — Environment/Superfund
Monitoring Environmental, Social and Governance (ESG) issues Issues related to the sterilization of medical devices Issues related to the use of polyfluoroalkyl substances
Government entities lobbied: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE
CSP — Consumer Issues/Safety/Products
Issues related to data privacy and data security Issues related to artificial intelligence enabled medical devices and emerging technologies Issues related to right to repair
Government entities lobbied: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)
VET — Veterans
Issues related to hypertension Issues related to procurement of healthcare technologies
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
DEF — Defense
Issues related to the National Defense Authorization Act for Fiscal Year 2027 including servicing and repair of medical devices
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/Appropriations
Issues related to hypertension, including FY27 MilCon/Veterans Appropriations Issues related to overactive bladder and urinary incontinence, including FY27 Labor/HHS Appropriations
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
CIV — Civil Rights/Civil Liberties
Issues related to third party litigating funding
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE